AT

Amit Turrey

Active Director Director DIN 07018840
DIN 07018840 First appointment Dec 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value •••• Premium profile

About Amit Turrey

Data last updated:

Amit Turrey is a Director at Mendbrisk Pharmaceuticals Private Limited (since 2014). The company operates in Trading. Mendbrisk Pharmaceuticals Private Limited reported revenue of ₹10.8 Lakh (FY 2021).

DIN 07018840
Primary Designation Director
Industry Trading
First Appointment 05 Dec 2014
Oldest Company Age 11 yrs
Largest company Mendbrisk Pharmaceuticals Private Limited · ₹10.8 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Dec 20142014₹10.8 Lakh (FY 2021)Active

Board colleagues of Amit Turrey

Directorship timeline

Open interactive timeline →
Mendbrisk Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Turrey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Turrey

Amit Turrey currently holds 1 directorship: Mendbrisk Pharmaceuticals Private Limited (Director, since 05 Dec 2014, revenue ₹10.8 Lakh (FY 2021)).

Amit Turrey was first appointed on 05 Dec 2014 as Director at Mendbrisk Pharmaceuticals Private Limited.

The current boards of Amit Turrey's companies include Dhirendra Dinakar Kukde (Mendbrisk Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available